0 Canadian Stock Exchange News - October 16, 2024Yukon Metals Announces 2.4% Copper and Gold Values up to 6.64 g/t in Multiple Rock-Chip Samples at BirchVANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF), the “Company” […]Read More
0 NYSE Companies - October 16, 2024RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for DesignSmith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure […]Read More
0 NYSE Companies - October 16, 2024Les Vêtements de Sport Gildan annonce la date de publication de ses résultats financiers du troisième trimestre de 2024MONTRÉAL, 16 oct. 2024 (GLOBE NEWSWIRE) — Les Vêtements de Sport Gildan Inc. (TSX et NYSE : GIL) publiera ses […]Read More
0 NYSE Companies - October 16, 2024Gildan Activewear Announces Date for Third Quarter 2024 Earnings ReleaseMONTREAL, Oct. 16, 2024 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL; TSX and NYSE) will report its 2024 third quarter […]Read More
0 NYSE Companies - October 16, 2024Ocean Power Technologies to exhibit Autonomous Vehicle Services at ADIPEC with Unique GroupMONROE TOWNSHIP, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), […]Read More
0 NYSE Companies - October 16, 2024Brink’s Schedules Third-Quarter 2024 Earnings Release and Conference Call for November 6, 2024RICHMOND, Va., Oct. 16, 2024 (GLOBE NEWSWIRE) — The Brink’s Company (NYSE:BCO), a leading global provider of cash and valuables […]Read More
0 TSX Venture News - October 16, 2024Torr Metals Mobilizes Crews to Filion Gold Project, Testing Major Expansion Potential Along Trans-Canada Highway 11VANCOUVER, British Columbia, Oct. 16, 2024 (GLOBE NEWSWIRE) — via IBN — Torr Metals Inc. (“Torr” or the “Company“) (TSX-V: […]Read More
0 NYSE Companies - October 16, 2024Theriva Biologics Announces Orphan Medicinal Product Designation Granted by the European Commission to VCN-01 for the Treatment of RetinoblastomaROCKVILLE, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) — Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a clinical-stage company […]Read More